SIZE XSSIZE SMSIZE MDSIZE LG

BCOP 2019 Self-Study Online Module Release II

BCOP Self-Study Online Modules - both releases will cover topics from all the BCOP domains and multiple hematology/oncology patient populations, and feature recent articles from primary oncology literature. BCOP Self-Study Modules are on-demand and allow you to review at your convenience.

Each module will include access to articles, pre-assessment questions, patient cases and the BCOP posttest. You may choose to complete all or select individual modules, receiving BCOP credit for each completed module which achieves a passing score.

Case study questions will count towards the overall test score for the BCOP credit. Your results in the case studies and the posttest questions will determine your total score which still must meet the 75% threshold for passing to earn BCOP credit.

Your purchase of Self-Study Release II includes 3 modules and offers up to 7.5 BCOP/ACPE credits.

Module 5: Chronic Graft-versus-Host Disease (2.5 BCOP/ACPE)

Module 6: Adolescent and Young Adult (AYA) (2.5 BCOP/ACPE)

Module 7: Pharmacy Accreditation (2.5 BCOP/ACPE)

HOPA Member Price: $165

Non-Member Price: $225

Purchase now

2019 BCOP Self-Study Online Module – Release II is also a part of both the 2019 BCOP Program Bundle and BCOP Self-Study Online Module Bundle. If you’ve already purchased the 2019 BCOP Program Bundle or BCOP Self-Study Online Module Bundle, you can access your Self-Study Modules in My Education Library.

Credit Designation

Accreditation Statement:

 logo acpeThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE credit must be claimed by August 31, 2022.

education speaker bpslogo The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certification oncology credit (BCOP). A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form, case-study and post-test, with a combined passing grade of 75% or greater is achieved. Tests must be completed by February 28, 2020.

Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.

Reported Areas of Conflict: Planners and Managers Hematology/Oncology Pharmacy Association does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced, objective, and scientifically rigorous. Occasionally, authors may express opinions that represent their own viewpoint. Conclusions drawn by participants should be derived from objective analysis of scientific data. Unlabeled/unapproved uses of drugs. All faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs and devices.


Module 5: Chronic Graft-versus-Host Disease

Description: tbd

Learning Objectives

Speaker: tbd

Disclosure:tbd

Target Audience

This activity is intended for intermediate/advanced hematology/oncology pharmacists. This activity has been approved for 2.5 contact hours (.25 CEUs) under the ACPE universal activity number .

Activity Type: Application


Module 6: Adolescent and Young Adult

Description: TBD

Learning Objectives

Speaker: tbd

Disclosure: tbd.

Target Audience

This activity is intended for intermediate/advanced hematology/oncology pharmacists. This activity has been approved for 2.5 contact hours (.25 CEUs) under the ACPE universal activity number .

Activity Type: Application


Module 7: Pharmacy Accreditation

Description:tbd

Learning Objectives

Speaker:tbd

Disclosures: tbd.

Target Audience

This activity is intended for intermediate/advanced hematology/oncology pharmacists. This activity has been approved for 2.5 contact hours (.25 CEUs) under the ACPE universal activity number .

Activity Type: Application



 

 

 

xs
sm
md
lg